FRBT heads into its August 14 earnings report with a newly assembled analyst following and a borrow market that has transformed almost beyond recognition in the past six weeks.
The ownership story sets the context. Forbright only recently became a publicly traded entity in its current form, and that novelty shows up in the data. Three firms — Goldman Sachs, Barclays, and Wells Fargo — initiated coverage on July 6, all with bullish ratings. JP Morgan initiated the same day with Neutral. The coverage wave was immediate and broad: within five weeks of those initiations, both Wells Fargo and JP Morgan had already raised their price targets. Wells Fargo lifted its target to $22 on August 10, just days before the print, while JP Morgan moved to $23 from $21 on July 31. With the stock at $19.35 and the consensus mean target near $22.92, the Street is pricing in roughly 18% upside from current levels — meaningful conviction for a bank that has barely been publicly covered.
The lending market tells an equally striking story. Through late June and early July, availability was genuinely tight — nearly 70% of the borrowable pool was lent out at one point on July 6, with availability running below 90% of outstanding short interest. That is the kind of scarcity that makes shorting expensive and mechanically difficult. Since then, short interest collapsed by roughly 85% over the past month, falling from over 430,000 shares to around 64,000. Availability has swung to the other extreme — now essentially unconstrained, with more than 4.3 million shares available to borrow against a tiny short base. Cost to borrow, however, has stayed elevated at around 19%, well above what you'd expect for a stock with negligible short demand. That mismatch — abundant supply, high cost — likely reflects the stock's relative illiquidity and thin institutional float rather than any short-side pressure.
Concentration is the other feature worth noting. Three holders — Gallatin Point Capital, Centerbridge Partners, and Bayview Asset Management — together own more than 51% of shares. That degree of lock-up constrains the free float materially, which explains the historically erratic borrow dynamics. The stock has drifted about 4% lower over the past month and slipped nearly 3% on the week, despite a 1.4% bounce on August 10. The bank trades at roughly 10.6x earnings and 0.9x book value — modest multiples that reflect either genuine value or lingering uncertainty about the growth model.
The August 14 print is therefore the first real test of whether the freshly minted analyst consensus — broadly bullish, with targets clustered in the $21–$23.50 range — holds up against actual reported numbers from a bank that the market is still learning to price.
See the live data behind this article on ORTEX.
Open FRBT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
